NCT03814239

Brief Summary

In the present retrospective study, it was hypothesized that application, in scoliosis surgery, of a protocol for blood and fluid management, based on goal directed fluid therapy, cell salvage and tranexamic acid, could lead to reduced allogeneic red blood cells transfusion. The patients will be enrolled in a retrospective observational study and divided in two groups. Patients in no protocol Group received a liberal intraoperative fluid therapy and patients in protocol Group received fluid therapy managed according to a stroke volume variation based protocol. The protocol included fluid therapy according to SVV monitor, permissive hypotension, tranexamic acid infusion, restrictive RBC trigger and use of perioperative cell savage.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2011

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2016

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

January 20, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 23, 2019

Completed
Last Updated

February 8, 2019

Status Verified

January 1, 2019

Enrollment Period

5.1 years

First QC Date

January 20, 2019

Last Update Submit

February 6, 2019

Conditions

Keywords

transfusiongoal directed fluid therapy

Outcome Measures

Primary Outcomes (1)

  • units of red blood cells transfused

    the overall units of red blood cells transfused during surgery. Hb\< 7 was the trigger for transfusion in protocol group and Hb\<8 for no transfusion group.

    intraoperative

Secondary Outcomes (4)

  • volume of crystalloids infused

    intraoperative

  • volume of colloids infused

    intraoperative

  • infused vasopressors

    intraoperative

  • diuresis

    intraoperative

Study Arms (2)

no protocol

liberal fluid therapy

protocol

fluid therapy according to stroke volume variation (SVV) monitor, tranexamic acid administration, use of cell saver

Other: protocol

Interventions

In patients of Group Protocol , basal crystalloid infusion was started at 4 ml/kg/h right after general anesthesia induction and intubation. ClearSight System (Edwards Lifesciences Cop, Irvine, CA, USA) was used to measure stroke volume variation and cardiac output, continuously and noninvasively through finger- cuffed technology. If SVV was \>15% rapid crystalloid bolus of 10ml/kg or 4ml/kg colloid bolus were administered until it reached a value of ≤15%. After two consecutive fluid boluses SVV remained \>15%, administration of noradrenaline infusion was considered.

protocol

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled for elective orthopaedic surgery of scoliosis, with a planned intensive care unit admission, were enrolled in a retrospective observational study.

You may qualify if:

  • severe curve (Cobb Angle \> 70-degree)
  • same surgeon in all procedures

You may not qualify if:

  • Patients with coagulopathy,
  • morbid obesity
  • severe cardiopulmonary disease
  • liver dysfunction
  • renal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

George Papanikoalou Hospital

Thessaloniki, 57010, Greece

Location

Related Publications (1)

  • Koraki E, Stachtari C, Stergiouda Z, Stamatopoulou M, Gkiouliava A, Sifaki F, Chatzopoulos S, Trikoupi A. Blood and fluid management during scoliosis surgery: a single-center retrospective analysis. Eur J Orthop Surg Traumatol. 2020 Jul;30(5):809-814. doi: 10.1007/s00590-020-02637-y. Epub 2020 Feb 3.

MeSH Terms

Conditions

Scoliosis

Interventions

Clinical Protocols

Condition Hierarchy (Ancestors)

Spinal CurvaturesSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsEpidemiologic Study CharacteristicsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and Evaluation

Study Officials

  • Anastasia Trikoupi

    Director of Anesthesiology Department

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Stachtari Chrysoula, Consultant Anesthesiologist, G. Papanikolaou hospital

Study Record Dates

First Submitted

January 20, 2019

First Posted

January 23, 2019

Study Start

October 30, 2011

Primary Completion

November 20, 2016

Study Completion

January 1, 2019

Last Updated

February 8, 2019

Record last verified: 2019-01

Locations